Electrode lead wire reg based on international standards sought by device manufacturers.
This article was originally published in The Gray Sheet
Executive Summary
PATIENT ELECTRODE LEAD WIRE REGULATION BASED ON VOLUNTARY STANDARDS is recommended by Medtronic, Bard, and 3M Health Care in recent comments on FDA's proposed mandatory performance standard for the devices. "In lieu of a mandatory performance standard," Medtronic says, FDA should require manufacturers of electrode lead wires to "certify that their leads comply with a recognized voluntary standard when a device is reviewed through the 510(k)" or premarket approval process.
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.